Here are four companies Orlando Health is investing in:
- Orlando Health Ventures joined with other health systems in a $6.3 million series B round for medical device company 410 Medical.
- The health system led a $21.5 million series B financing round for biotech company Vergent Bioscience.
- In June 2021, the health system joined in a $245 million series D financing round for medical device maker Quanta.
- The health system co-led a series C financing round for medical devicemaker BioStable.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
